She warned there were still key unknowns about the results, however, including how long the protection against the virus might last and whether some cohorts of trial participants may not be seeing benefits from the vaccine.
The Pfizer product, known as BNT162b2, has already been granted a provisional determination by Australia's Therapeutic Goods Administration, which paves the way for Pfizer to apply for a provisional registration of the product.and began this process on Monday. CSL will also make the University of Queensland's vaccine if it passes trials.
MsEmmaK Hang on, can you verify this story? Apparently 40K people with covid, 94 patients were chosen of which 8 received the vaccine (the others placebo). Before we start talking about a vaccine for billions of people let’s get a bit of perspective first.....